Nasus Pharma Ltd. (NYSEAM: NSRX)
Health Care · Pharmaceuticals · IL
$3.63
-7.40% today · -44.4% 1Y
Nasus Pharma Ltd. (NYSEAM: NSRX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $45.92M and employs 7 people.
Over the last twelve months the share price has lost 44.4%, trading between 1.98 and 9.50.
Tweenvest scores Nasus Pharma Ltd. across four factors: quality 44/100, value 21/100. Its strongest factor is quality.
NSRX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $45.92M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.07
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $9.50
- 52-week low
- $1.98
- Avg volume (3M)
- —
- Shares outstanding
- 11.71M
- Employees
- 7
- Next earnings
- —
About Nasus Pharma Ltd.
Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-Yafo, Israel.
- ISIN
- IL0012181553
- Founded
- 2019
- Listed since
- Aug 13, 2025
- Exchange
- NYSE American LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Haleos Labs LimitedNSEI: HALEOSLABS | $46.79M | Rs1,490.00 | -0.79% |
| Trident Lifeline LimitedBSE: 543616 | $46.64M | Rs376.35 | -7.69% |
| Orexo AB (publ)OM: ORX | $46.63M | Skr6.85 | -48.88% |
| Decibel Cannabis Company Inc.TSXV: DB | $46.40M | CA$1.68 | -2.33% |
| Impact BioMedical Inc.NYSEAM: IBO | $45.45M | $4.11 | -22.75% |
| LeonaBio, Inc.NasdaqCM: LONA | $45.41M | $5.75 | +19.29% |
| Filana Therapeutics, Inc.NasdaqCM: FLNA | $44.97M | $0.81 | -12.60% |
| Pharmedic Pharmaceutical Medicinal Joint Stock CompanyHNX: PMC | $44.86M | ₫124,900.00 | +0.08% |
Figures last refreshed Oct 4, 2026.